About: CUTANEOUS DRUG ERUPTIONS ASSOCIATED WITH COVID-19 THERAPY

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CUTANEOUS DRUG ERUPTIONS ASSOCIATED WITH COVID-19 THERAPY Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	CUTANEOUS DRUG ERUPTIONS ASSOCIATED WITH COVID-19 THERAPY
Creator	Atzori, Laura Laura, Atzori Rongioletti, Franco Atzori, Maria Ferreli, Caterina Perla, Stefania
source	Elsevier; PMC
abstract	covid:1656e8e95711763ddbb9e62318355f7e779cd541#abstract
has issue date	2020-06-05(xsd:dateTime)
bibo:doi	10.1016/j.jdin.2020.05.004
has license	els-covid
sha1sum (hex)	1656e8e95711763ddbb9e62318355f7e779cd541
schema:url	https://doi.org/10.1016/j.jdin.2020.05.004
resource representing a document's title	CUTANEOUS DRUG ERUPTIONS ASSOCIATED WITH COVID-19 THERAPY
has PubMed Central identifier	PMC7274587
resource representing a document's body	covid:1656e8e95711763ddbb9e62318355f7e779cd541#body_text
is schema:about of	named entity 'drug-related' named entity 'hydroxychloroquine' named entity 'medical community' named entity 'human immunodeficiency virus' named entity 'risk factors' named entity 'AGEP' named entity 'azithromycin' named entity 'COVID-19' named entity 'concomitant drugs' named entity 'drug eruptions' named entity 'Symptomatic treatment' named entity 'cardiac arrhythmia' named entity 'case-control' named entity 'Food and Drug Administration' named entity 'vaccine' named entity 'Epstein-Barr virus' named entity 'Systemic corticosteroids' named entity 'acute generalized exanthematous pustulosis' named entity 'itching' named entity 'COVID-19' named entity 'eosinophilia' named entity 'angioedema' named entity 'adverse events' named entity 'COVID' named entity 'emergency conditions' named entity 'COVID' named entity 'Antibiotics' named entity 'Dermatologists' named entity 'pharmacovigilance' named entity 'cutaneous' named entity 'drug interactions' named entity 'skin reaction' named entity 'European Medicines Agency' named entity 'DRESS' named entity 'toxic epidermal necrolysis' named entity 'COVID-19 pandemic' named entity 'antihistamines' named entity 'maculopapular' named entity 'cutaneous' named entity 'ebastine' named entity 'remdesivir' named entity 'AGEP' named entity 'toxic epidermal necrolysis' named entity 'toxicity' named entity 'COVID-19' named entity 'drug reaction' named entity 'Cetirizine' named entity 'toxic epidermal necrolysis' named entity 'human herpesvirus 6' named entity 'delayed hypersensitivity reactions' named entity 'Italian' named entity 'systemic symptoms' named entity 'Tocilizumab' named entity 'prolong the QT interval' named entity 'mizolastine' named entity 'drug interactions' named entity 'adverse drug reactions' named entity 'cutaneous' named entity 'CYp450' named entity 'cytochrome enzymes' named entity 'metabolites' named entity 'antiretrovirals' named entity 'Intravenous immunoglobulins' named entity 'coronavirus disease' named entity 'cytomegalovirus' named entity 'urticaria' named entity 'DRESS' named entity 'virus' named entity 'CUTANEOUS' named entity 'DRUG ERUPTIONS' named entity 'COVID-19' named entity 'PROOF' named entity 'PRE' named entity 'THERAPY' named entity 'COVID-19' named entity 'ASSOCIATED WITH' named entity 'DRUG ERUPTIONS' named entity 'JOURNAL ' named entity 'Journal'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software